Psychopharmacology and Psychiatry Updates
Un pódcast de Psychopharmacology Institute
Categorías:
252 Episodo
-
Rethinking Antipsychotic Dosing: Lessons from the RADAR Trial
Publicado: 6/1/2025 -
Unraveling Agitation: Mania vs. Substance Use
Publicado: 1/1/2025 -
Pushing the Boundaries: Exploring High-Dose Antipsychotics
Publicado: 27/12/2024 -
The Psychodynamic Prescriber
Publicado: 22/12/2024 -
From Inpatient to Outpatient: Initiating Benzodiazepine Tapering
Publicado: 17/12/2024 -
The Power of Alliance in Psychopharmacology
Publicado: 12/12/2024 -
Antipsychotics in Youth: Balancing Metabolic Risk
Publicado: 7/12/2024 -
The Double-Edged Sword of Biological Explanations in Mental Health
Publicado: 2/12/2024 -
New Insights into Psychiatric and Cardiovascular Comorbidity
Publicado: 27/11/2024 -
Beyond the Pill: The Psychology of Psychopharmacology
Publicado: 22/11/2024 -
On Methylphenidate and Sleep: A Two-Year Study
Publicado: 17/11/2024 -
Nature's Pharmacy: Combining Natural Remedies in Psychiatry
Publicado: 12/11/2024 -
Breaking the Cycle: Memantine in Body-Focused Repetitive Behaviors
Publicado: 7/11/2024 -
The Potential of Ashwagandha in Psychiatry
Publicado: 2/11/2024 -
Treatment Dilemmas: ECT for Depressed Teens
Publicado: 28/10/2024 -
CBD in Psychiatry: Promise or Hype?
Publicado: 23/10/2024 -
Beyond Dopamine: Cannabidiol in Parkinson's Care
Publicado: 18/10/2024 -
Is NAC Promising in Bipolar and Depression Treatment?
Publicado: 13/10/2024 -
Microbes and the Mind: Probiotics and ADHD
Publicado: 8/10/2024 -
Lithium, Lamotrigine, and Labor: Managing Bipolar Disorder in Expectant Mothers
Publicado: 3/10/2024
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.